|
|
ICD-10 (CM) Code and Descriptor
|
D49.6 |
Neoplasm of unspecified behavior of brain
|
D496 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 45.19%
|
21.65%
|
11.03%
|
7.08%
|
4.46%
|
3.12%
|
1.96%
|
1.36%
|
1.02%
|
0.75%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D49.6*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
2,789
|
2,796
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,196
|
2,215
|
|
97110
|
THERAPEUTIC EXERCISES |
1,718
|
3,019
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,449
|
1,469
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,423
|
1,426
|
|
97530
|
THERAPEUTIC ACTIVITIES |
1,369
|
2,764
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,259
|
1,262
|
|
A9585
|
GADOBUTROL INJECTION |
1,029
|
78,545
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
936
|
1,537
|
|
G1004
|
CDSM NDSC |
889
|
965
|
|
82565
|
ASSAY OF CREATININE |
660
|
662
|
|
70450
|
CT HEAD/BRAIN W/O DYE |
653
|
654
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
608
|
81,707
|
|
92507
|
TX SP LANG VOICE COMM INDIV |
605
|
605
|
|
A9577
|
INJ MULTIHANCE |
553
|
8,527
|
|
93005
|
ELECTROCARDIOGRAM TRACING |
481
|
491
|
|
97116
|
GAIT TRAINING THERAPY |
467
|
679
|
|
97535
|
SELF CARE MNGMENT TRAINING |
425
|
786
|
|
85610
|
PROTHROMBIN TIME |
408
|
409
|
|
99285
|
EMERGENCY DEPT VISIT HI MDM |
404
|
404
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D49.6 related to the following DRG Codes:
054-055
|
